AstraZeneca said on Monday its vaccine for the novel coronavirus could be around 90% effective without any serious side ...
The European Union reached a deal with Pfizer and BioNTech for 300 million additional doses of their COVID-19 vaccine, the ...
Discover why Pfizer Inc. is rated a Strong Buy with 33% upside, robust dividends, and growth prospects ahead. Click for my updated look at PFE stock.
The fall COVID-19 vaccine season is starting slowly for Pfizer, with U.S. sales of its Comirnaty shots sinking 25% after federal regulators narrowed recommendations on who should get them.
Pfizer’s pricing deal with the Trump administration, which won the company a three-year exemption from sector-specific ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback